Navigation Links
ADVENTRX Pharmaceuticals Provides Update on ANX-514
Date:2/15/2011

events or results may differ materially from those expressed or implied by the forward-looking statements in this press release due to a number of risks and uncertainties, including, without limitation: the potential for the FDA to require significant further nonclinical studies and/or clinical testing of ANX-514, including more than one clinical trial, which generally are more costly and lengthy than bioequivalence trials; the risk that additional nonclinical and/or clinical activities required by the FDA prior to the filing or the approval of a New Drug Application (NDA) for ANX-514 may result in ADVENTRX's determination that the commercial potential of ANX-514 does not justify the required investment and ADVENTRX's discontinuation of the program; the risk that, if ADVENTRX determines to continue development of ANX-514, ADVENTRX may need to raise additional capital to fund the additional development activities required by the FDA and that the necessity of such activities may negatively impact ADVENTRX's ability to raise additional capital for development of and/or partner ANX-514; difficulties or delays in manufacturing ANX-514 for additional clinical or bioequivalence studies; difficulties or delays in obtaining regulatory approval for ANX-514, even if ADVENTRX conducts additional nonclinical and/or clinical activities required by the FDA, including the potential for automatic injunctions regarding FDA approval of ANX-514 and other challenges by patent holders during the Section 505(b)(2) process; difficulties or delays in manufacturing and marketing ANX-514, including validating commercial manufacturing processes and manufacturers, as well as suppliers; ADVENTRX's reliance on the performance of third parties to assist in the conduct of its nonclinical, clinical and bioequivalence studies, regulatory submissions, CMC activities, commercial launch activities and other important aspects of the Exelbine and ANX-514 development programs, and that such third parties
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
2. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
3. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
4. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
5. ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing
6. ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million
7. ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics
8. ADVENTRX Pharmaceuticals to Present at the 4TH Annual OneMedForum Business Development and Investment Conference on January 11
9. ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study
10. ADVENTRX Reports Third Quarter Financial Results
11. ADVENTRX to Present at the Wall Street Analyst Forum 21st Annual Institutional Investor Conference on November 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Medical science liaisons (MSLs) play ... opinion leaders (KOLs) who can provide essential insights ... nature of the MSL function, the changing regulatory ... landscape for creating and maintaining KOL and physician ... oversight responsibility for the MSL function is increasingly ...
(Date:9/19/2014)... The Parenteral Drug Association (PDA) is moving ... protocols. The new initiative stems from ... industry participants and regulatory authority representatives at the PDA ... Washington, DC . Representatives of both the ... workshop. Attendees indicated openness to engaging regulators and industry ...
(Date:9/19/2014)... 2014 Kiromic, LLC, a Lubbock ... Hance , the former chancellor of Texas Tech University, to ... in July 2014, after raising $1.2 billion for the university. ... Hance , the most successful chancellor in the history of ... as an investor, but also as our new vice chairman ...
Breaking Medicine Technology:Role of Medical Science Liaisons Shifting in Healthcare Industry 2PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2
... N.C., March 5, 2012  Chimerix, Inc., a biotechnology company ... Moch, President and Chief Executive Officer, will present at ... Tuesday, March 6, 2012 at 3:00 pm ET at ... Mr. Moch,s presentation will include an update on ...
...   Process Seals recently expanded its portfolio of ... white material specifically developed to meet the requirements of ... and biotech industries. The white 70 EPDM ... parts and butterfly valve seals in hygienic applications where ...
Cached Medicine Technology:Chimerix to Present at Cowen and Company's 32nd Annual Health Care Conference 2Chimerix to Present at Cowen and Company's 32nd Annual Health Care Conference 3Process Seals Develops White Hygienic Sealing Material for Pharmaceutical, Food and Beverage, and Biotech Applications 2
(Date:9/21/2014)... Want to understand why cancer cells metastasize? Think of ... diet that better prepared them for the demands of ... do the same thing according to a new study ... to grow at the original tumor site, and those ... cancer cell,s unyielding ability to metastasize is the primary ...
(Date:9/21/2014)... 21, 2014 (HealthDay News) -- Young women starting college ... which foods they should eat. But they aren,t confident ... according to a new study. The study ... of Illinois,s Peer Education Exercising and Eating Right program. ... they choose to eat if they were very busy ...
(Date:9/21/2014)... To accommodate the ever-growing customer base, Angeldress.co.uk ... trendy items. Recently, the company has unveiled its 2014 ... and elegant wedding gowns, Angeldress.co.uk wants to make sure ... an easy way. Its high quality vintage wedding outfits ... off to 62% off. , Online shopping is becoming ...
(Date:9/21/2014)... BambooIndustry.com, an experienced producer of natural bamboo items, has ... http://www.bambooindustry.com/products/bamboo-panel/ ). The company’s excellent panels are very popular ... discounted prices now, from 10 to 30 percent off. ... are available in many specifications; they are promised to ... finely manufactured by qualified workers. They are specially offered ...
(Date:9/21/2014)... Top10BestSEOHosting.com, a leading review website, ... GreenGeeks are the most recommended hosting suppliers for ... quality hosting products. , “Don’t waste your ... recommend two great hosting companies to you,” the ... iPage and GreenGeeks are the most recommended suppliers ...
Breaking Medicine News(10 mins):Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2
... A U. S manufactured drug DCVax Brain, targeting brain ... Switzerland . , The Bothell-based biotech company Northwest ... works by empowering the immune system to fight off ... to gain access to American and European markets, the ...
... for eating uncooked fish dishes like koi-pla puts people ... can cause a type of liver cancer called ... this weeks PLoS Medicine. ,Banchob Sripa (Khon ... the food-borne trematode Opisthorchis viverrini (the SE Asian liver ...
... new study, published in the July issue of CHEST, the ... (ACCP), shows that a low dietary intake of certain nutrients ... in teens who smoke. ,Teenagers who forego a ... their breath. Furthermore, a lack of these nutrients may also ...
... UK s 119 million pound campaign to boost fruit and vegetable ... . , Professor Janet Cade and colleagues of ... Scheme (SFVS), installed in 2004, on 3,700 young students from 98 ... children was used to assess dietary and nutrient intake. , ...
... claims they can soon release the worlds first blood test ... Trust of UK will stand to save billions of pounds per ... diseases in the western world, costs the NHS up to 17 ... identified a series of proteins, which are most commonly found in ...
... called on the country Wednesday to launch a major clean-up of ... ,"We have to clean our cities or risk losing ... group, which includes the five-star Oberoi chain. ,"Water is ... a mess. Cleaning up our cities must happen," he told reporters. ...
Cached Medicine News:Health News:Apple a Day Keeps Asthma Away 2Health News:Apple a Day Keeps Asthma Away 3Health News:Britains Free Fruit -And -Vegetable -Scheme Falls Flat 2Health News:Simple Blood Test May Predict Alzheimers Disease 2
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 90 degrees....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 45 degrees....
6 mm tying platform. Round knurled handle with polished finish. Teeth: 0.3 mm, 1 x 2. Orientation: Left hand....
0.12 mm, 1 x 2 teeth set at 45 degrees with 6 mm tying platform. Wide serrated handle with polished finish....
Medicine Products: